
Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA)
Keywords: GCP-II; glutamate carboxypeptidase-II; PSMA; prostate specific membrane antigen; NAALADase; N-acetylated-alpha-linked acidic dipeptidase; NAAG; N-acetyl-aspartyl glutamate; 2-PMPA; 2-phosphonomethyl pentanedioic acid; 2-PMSA; 2-phosphonomethyl succinic ac